These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7852226)

  • 21. Comparative bioavailability of two tablet preparations of diltiazem in healthy volunteers.
    De Bernardis E; Candido P; Lorefice R; Picari M; Rizza V
    Arzneimittelforschung; 1992 Jan; 42(1):25-7. PubMed ID: 1586376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pro-lipidaemic effect.
    Das Gupta R
    J Indian Med Assoc; 1990 Dec; 88(12):346. PubMed ID: 2074357
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers.
    Bano G; Raina RK; Zutshi U; Bedi KL; Johri RK; Sharma SC
    Eur J Clin Pharmacol; 1991; 41(6):615-7. PubMed ID: 1815977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of honey on orally and intravenously administered diltiazem kinetics in rabbits.
    Koumaravelou K; Adithan C; Shashindran CH; Asad M; Abraham BK
    Indian J Exp Biol; 2002 Oct; 40(10):1164-8. PubMed ID: 12693698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and bioavailability of a sustained-release diltiazem formulation (Mono-Tildiem LP 300 MG) after repeated administration in healthy volunteers.
    Bianchetti G; Dubruc C; Sultana V; Houin G; Rosenzweig P
    Eur J Clin Pharmacol; 1995; 48(3-4):259-64. PubMed ID: 7589051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of nifedipine on the pharmacokinetics and dynamics of diltiazem: the preliminary study in normal volunteers.
    Tateishi T; Ohashi K; Sudo T; Sakamoto K; Fujimura A; Ebihara A
    J Clin Pharmacol; 1993 Aug; 33(8):738-40. PubMed ID: 8408735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced Oral Bioavailability of Diltiazem by the Influence of Gallic Acid and Ellagic Acid in Male Wistar Rats: Involvement of CYP3A and P-gp Inhibition.
    Athukuri BL; Neerati P
    Phytother Res; 2017 Sep; 31(9):1441-1448. PubMed ID: 28766866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PK/PD modelling of high-dose diltiazem--absorption-rate dependency of the hysteresis loop.
    Luckow V; Della Paschoa O
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):418-25. PubMed ID: 9352390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo performance of controlled release pellets of diltiazem HCl.
    Nisarur-ur-Rahman ; K H Y; Jia Woei W
    Pak J Pharm Sci; 2005 Apr; 18(2):44-8. PubMed ID: 16431398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability of diltiazem as a function of the administered dose.
    Bianchetti G; Regazzi M; Rondanelli R; Ascalone V; Morselli PL
    Biopharm Drug Dispos; 1991 Jul; 12(5):391-401. PubMed ID: 1878535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of effect of grapefruit juice on diltiazem bioavailability in normal subjects.
    Sigusch H; Henschel L; Kraul H; Merkel U; Hoffmann A
    Pharmazie; 1994 Sep; 49(9):675-9. PubMed ID: 7972311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and bioavailability of diltiazem sustained-release: influence of food and time of administration.
    Bianchetti G; Bagheri H; Houin G; Dubruc C; Thénot JP
    Fundam Clin Pharmacol; 1995; 9(2):197-201. PubMed ID: 7628834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steady state relative bioavailability and pharmacokinetics of oral propranolol in black and white North Americans.
    Sharoky M; Perkal M; Turner R; Lesko LJ
    Biopharm Drug Dispos; 1988; 9(5):447-56. PubMed ID: 3224162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of hesperidin on the oral pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
    Cho YA; Choi DH; Choi JS
    J Pharm Pharmacol; 2009 Jun; 61(6):825-9. PubMed ID: 19505375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of a novel diltiazem HCl extended-release tablet formulation for evening administration.
    Sista S; Lai JC; Eradiri O; Albert KS
    J Clin Pharmacol; 2003 Oct; 43(10):1149-57. PubMed ID: 14517197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of sensory (teasing) exposure to food on oral propranolol bioavailability.
    Power JM; Morgan DJ; McLean AJ
    Biopharm Drug Dispos; 1995 Oct; 16(7):579-89. PubMed ID: 8785381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interaction of diltiazem with lovastatin and pravastatin.
    Azie NE; Brater DC; Becker PA; Jones DR; Hall SD
    Clin Pharmacol Ther; 1998 Oct; 64(4):369-77. PubMed ID: 9797793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vanillin enhances the passive transport rate and absorption of drugs with moderate oral bioavailability in vitro and in vivo by affecting the membrane structure.
    Huang W; Yang Y; Wen W; Luo Y; Wu J; Xiang L; Hu Y; Xu S; Chen S; Wang P
    Food Funct; 2020 Jan; 11(1):700-710. PubMed ID: 31909774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers.
    Korhonen O; Kanerva H; Vidgren M; Urtti A; Ketolainen J
    J Control Release; 2004 Mar; 95(3):515-20. PubMed ID: 15023462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats.
    Hong SP; Choi DH; Choi JS
    Cardiovasc Ther; 2008; 26(4):269-75. PubMed ID: 19035878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.